SCHEMBL4378739

SCHEMBL4378739

CC(C)(O)CC[C@H](C[C@H](O)C(=O)NCc1cccs1)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.47
TSHR P16473 2/20 0.42
GAA P10253 3/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.40
MAPT P10636 2/20 0.40
CCR1 P32246 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
USP2 O75604 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7688715 0.78 CCR1 (0.37) POLBTSHRALDH1A1CCR1SMN1; SMN2
SCHEMBL4066969 0.78 CCR1 (0.43) POLBTSHRCCR1CYP2D6CYP2C9
SCHEMBL8285113 0.71 POLB (0.58) POLBTSHRGAANPSR1ALDH1A1
SCHEMBL3035554 0.71 POLB (0.58) POLBTSHRGAANPSR1ALDH1A1
SCHEMBL10253878 0.70 GAA (0.60) POLBTSHRGAANPSR1ALDH1A1
SCHEMBL4066963 0.70 CTSC (0.35) POLBTSHRALDH1A1CCR1SMN1; SMN2
SCHEMBL1107021 0.68 GAA (0.62) POLBTSHRGAANPSR1ALDH1A1
SCHEMBL4069074 0.68 CCR1 (0.43) POLBTSHRCCR1CYP2D6CYP2C9
SCHEMBL17152584 0.67 TSHR (0.60) POLBTSHRGAANPSR1ALDH1A1
SCHEMBL4069071 0.67 CTSC (0.34) POLBTSHRALDH1A1CCR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966443-B1 HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE INHIBITORS OF MIP-1-ALPHA BINDING TO ITS CCR1 RECEPTOR PFIZER (US) 2009-01-28 EP disclosed
WO-2004039375-A1 METHODS OF USING CCR1 ANTAGONISTS AS IMMUNOMODULATORY AGENTS PFIZER PRODUCTS INC. (US) 2004-05-13 WO disclosed